BEAM

Beam Therapeutics

Biotech · 8 tracked clinical trials

Clinical Pipeline

TrialPhaseStatusIndication
NCT06389877 PHASE1, PHASE2 RECRUITING Alpha 1-Antitrypsin Deficiency
NCT05456880 PHASE1, PHASE2 ACTIVE_NOT_RECRUITING Sickle Cell Disease
NCT06735755 PHASE1, PHASE2 RECRUITING Glycogen Storage Disease Type Ia
NCT05885464 PHASE1, PHASE2 ACTIVE_NOT_RECRUITING Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia
NCT06934382 PHASE1 RECRUITING T-Cell Acute Lymphoblastic Leukemia/Lymphoma
NCT07304791 PHASE1 RECRUITING Healthy Subjects, Healthy Participant Study
NCT07373639 RECRUITING Hemoglobinopathy, Sickle Cell Disease
NCT06071377 RECRUITING Sickle Cell Trait

Partnerships & Collaborations

PartnerTypeAnnouncedDetails
No partnerships tracked yet.

Recent news

DateHeadlineSource
2026-08-31 How Beam Therapeutics uses OpenBlue to keep biotech research moving - Johnson Controls Google News
2026-08-31 Three Beam Therapeutics talks will be webcast from Boston and New York - Stock Titan Google News
2026-08-31 Beam Therapeutics to Participate in Upcoming September 2026 Investor Conferences - The Manila Times Google News
2026-08-30 Liquidity Mapping Around (BEAM) Price Events - Stock Traders Daily Google News
2026-08-27 Beam Therapeutics (BEAM) Earnings History & Trends - 247wallst.com Google News
2026-08-26 Beam Therapeutics (BEAM) Stock May Look Stretched As Sales Expectations Climb - Yahoo Finance Google News
2026-08-26 Beam Therapeutics (BEAM) Institutional Ownership 2026 - MarketBeat Google News
2026-08-25 H.C. Wainwright reiterates Beam Therapeutics stock rating at buy - Investing.com Google News
2026-08-25 BEAM Reiterated by HC Wainwright & Co. -- Price Target Maintained at $80 - GuruFocus Google News
2026-08-25 BEAM Stock Price, Quote & Chart - ChartMill Google News
2026-08-25 H.C. Wainwright reiterates Beam Therapeutics stock rating at buy - Investing.com Google News
2026-08-25 Beam Therapeutics Market Sentiment - Benzinga España Google News
2026-08-25 Beam Therapeutics (BEAM) Short Interest & Short Float | Updated Aug 2026 - MarketBeat Google News
2026-08-20 Beam Therapeutics (NASDAQ:BEAM) Stock Price Down 6.2% - Here's What Happened - MarketBeat Google News
2026-08-19 Beam Therapeutics (NASDAQ:BEAM) Shares Gap Up - Should You Buy? - MarketBeat Google News
2026-08-18 Alphabet Inc. Purchases New Shares in Beam Therapeutics Inc. $BEAM - MarketBeat Google News
2026-08-17 Beam Therapeutics Inc. (NASDAQ:BEAM) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat Google News
2026-08-16 Beam Therapeutics (NASDAQ:BEAM) Downgraded by Wall Street Zen to "Strong Sell" - MarketBeat Google News
2026-08-14 Beam Therapeutics (BEAM): ARK Investment and Cathie Wood report 9.95% stake - Stock Titan Google News
2026-08-13 Farallon funds report 10.28M-share, 9.99% Beam Therapeutics (BEAM) position - Stock Titan Google News